Wockhardt to set up its first manufacturing facility in Middle East
Drug firm Wockhardt has set up its first facility in the Middle East in Dubai for the manufacture of new chemical entities (NCEs) to cater to global markets.
Wockhardt is poised for a quantum leap into the future, he added.
The company, however, did not provide any details about the investments it has made for setting up the facility.
"With Wockhardt's commitment to research and development, we have 5 breakthroughs NCEs that have been accorded Qualified Infectious Disease Product (QIDP) status by USFDA," Khorakiwala said.
The five novel antibiotic drugs are in advanced stage of global clinical development, the company said.
Shares of Wockhardt were today trading at Rs 594.50 per scrip on BSE, up 2.74 per cent from the previous close.
(This story has not been edited by Devdiscourse staff and is auto-generated from a syndicated feed.)